Attached files
| file | filename |
|---|---|
| EX-99.2 - EX-99.2 - Onconova Therapeutics, Inc. | a2228844zex-99_2.htm |
| EX-99.7 - EX-99.7 - Onconova Therapeutics, Inc. | a2228844zex-99_7.htm |
| EX-99.6 - EX-99.6 - Onconova Therapeutics, Inc. | a2228844zex-99_6.htm |
| EX-99.5 - EX-99.5 - Onconova Therapeutics, Inc. | a2228844zex-99_5.htm |
| EX-99.4 - EX-99.4 - Onconova Therapeutics, Inc. | a2228844zex-99_4.htm |
| EX-99.3 - EX-99.3 - Onconova Therapeutics, Inc. | a2228844zex-99_3.htm |
| EX-99.1 - EX-99.1 - Onconova Therapeutics, Inc. | a2228844zex-99_1.htm |
| EX-4.5 - EX-4.5 - Onconova Therapeutics, Inc. | a2228844zex-4_5.htm |
| S-1 - S-1 - Onconova Therapeutics, Inc. | a2228844zs-1.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the reference to our firm under the caption "Experts" in the Registration Statement (Form S-1 No. 333- ) and related Prospectus of Onconova Therapeutics, Inc. and to the incorporation by reference therein of our report dated March 28, 2016, with respect to the consolidated financial statements of Onconova Therapeutics, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2015, filed with the Securities and Exchange Commission.
|
/s/ Ernst & Young LLP |
Philadelphia,
Pennsylvania
June 1, 2016
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM